Skip to main content
Top
Published in: Abdominal Radiology 2/2012

01-04-2012

Overload hepatitides: quanti-qualitative analysis

Authors: Luis Martí-Bonmatí, Angel Alberich-Bayarri, Javier Sánchez-González

Published in: Abdominal Radiology | Issue 2/2012

Login to get access

Abstract

Diffuse liver diseases have a definitive radiological importance due to the ability of MR imaging to demonstrate abnormalities before the patient is symptomatic or the liver damage is advanced. Biopsy procedures are invasive, may lead to complications and have a sample bias. Imaging biomarkers target to fat, water, and iron tissue concentrations may be considered as hepatic virtual biopsies. There is a need to identify a rapid and practicable method to accurately quantify liver steatosis, differentiate steatohepatitis from simple steatosis, grade the necroinflammatory activity, calculate the liver iron burden and monitor overload progression. MR is used in the evaluation of diffuse liver disorders with accurate approaches such as the use of chemical shift, Dixon vector analysis, turbo spin echo fat suppression, and T2* gradient echo techniques. These methods are influenced by some factors like proportional ambiguity, T1 and T2* effects on signal decay, adding a significant bias in the combined fat–water–iron quantification. A GRE multi-echo chemical shift sequence was configured to independently calculate fat, water, and iron parametric liver images. It is now necessary to conduct a pilot project in order to validate this method in a group of subjects without and with different grades of fat, water, and iron liver changes.
Literature
1.
go back to reference Martí-Bonmatí L, Talens A, del Olmo J, et al. (1993) Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation. Radiology 188:37–43PubMed Martí-Bonmatí L, Talens A, del Olmo J, et al. (1993) Chronic hepatitis and cirrhosis: evaluation by means of MR imaging with histologic correlation. Radiology 188:37–43PubMed
2.
go back to reference Yu H, Shimakawa A, McKenzie CA, et al. (2008) Multiecho water–fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60:1122–1134PubMedCrossRef Yu H, Shimakawa A, McKenzie CA, et al. (2008) Multiecho water–fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60:1122–1134PubMedCrossRef
3.
go back to reference Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF (2010) Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 16:1560–1566PubMedCrossRef Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF (2010) Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol 16:1560–1566PubMedCrossRef
4.
go back to reference Qayyum A, Goh JS, Kakar S, et al. (2005) Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques—initial experience. Radiology 237:507–511PubMedCrossRef Qayyum A, Goh JS, Kakar S, et al. (2005) Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques—initial experience. Radiology 237:507–511PubMedCrossRef
5.
go back to reference Hussain HK, Chenevert TL, Londy FJ, et al. (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display–early experience. Radiology 237:1048–1055PubMedCrossRef Hussain HK, Chenevert TL, Londy FJ, et al. (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display–early experience. Radiology 237:1048–1055PubMedCrossRef
6.
go back to reference Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA (1997) Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15:287–293PubMedCrossRef Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA (1997) Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15:287–293PubMedCrossRef
7.
go back to reference Westphalen AC, Qayyum A, Yeh BM, et al. (2007) Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242:450–455PubMedCrossRef Westphalen AC, Qayyum A, Yeh BM, et al. (2007) Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242:450–455PubMedCrossRef
8.
go back to reference Chitturi S, George J (2003) Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep 5:18–25PubMedCrossRef Chitturi S, George J (2003) Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. Curr Gastroenterol Rep 5:18–25PubMedCrossRef
9.
go back to reference El-Badry AM, Breitenstein S, Jochum W, et al. (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691–697PubMedCrossRef El-Badry AM, Breitenstein S, Jochum W, et al. (2009) Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg 250:691–697PubMedCrossRef
10.
go back to reference Lim RP, Tuvia K, Hajdu CH, et al. (2010) Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging. AJR Am J Roentgenol 194:1288–1295PubMedCrossRef Lim RP, Tuvia K, Hajdu CH, et al. (2010) Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging. AJR Am J Roentgenol 194:1288–1295PubMedCrossRef
11.
go back to reference Niederau C, Fischer R, Sonnenberg A, et al. (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256–1262PubMedCrossRef Niederau C, Fischer R, Sonnenberg A, et al. (1985) Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256–1262PubMedCrossRef
12.
go back to reference Villeneuve JP, Bilodeau M, Lepage R, Côté J, Lefebvre M (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 25:172–177PubMedCrossRef Villeneuve JP, Bilodeau M, Lepage R, Côté J, Lefebvre M (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 25:172–177PubMedCrossRef
13.
go back to reference Zhang X, Tengowski M, Fasulo L, Botts S (2004) Measurement of fat/water ratios in rat liver using 3D three-point Dixon MRI. Magn Reson Med 51:697–702PubMedCrossRef Zhang X, Tengowski M, Fasulo L, Botts S (2004) Measurement of fat/water ratios in rat liver using 3D three-point Dixon MRI. Magn Reson Med 51:697–702PubMedCrossRef
14.
go back to reference Reeder SB, McKenzie CA, Pineda AR, et al. (2007) Water–fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25:644–652PubMedCrossRef Reeder SB, McKenzie CA, Pineda AR, et al. (2007) Water–fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25:644–652PubMedCrossRef
15.
go back to reference Machann J, Thamer C, Schnoedt B, et al. (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913–917PubMedCrossRef Machann J, Thamer C, Schnoedt B, et al. (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913–917PubMedCrossRef
16.
go back to reference Boll DT, Marin D, Redmon GM, Zink SI, Merkle EM (2010) Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point Dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique. AJR Am J Roentgenol 194:964–971PubMedCrossRef Boll DT, Marin D, Redmon GM, Zink SI, Merkle EM (2010) Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point Dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique. AJR Am J Roentgenol 194:964–971PubMedCrossRef
17.
go back to reference Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 58:354–364PubMedCrossRef Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 58:354–364PubMedCrossRef
18.
go back to reference Longo R, Pollesello P, Ricci C, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285PubMedCrossRef Longo R, Pollesello P, Ricci C, et al. (1995) Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 5:281–285PubMedCrossRef
19.
go back to reference Marsman HA, van Werven JR, Nederveen AJ, et al. (2010) Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy. J Magn Reson Imaging 32:148–154PubMedCrossRef Marsman HA, van Werven JR, Nederveen AJ, et al. (2010) Noninvasive quantification of hepatic steatosis in rats using 3.0 T 1H-magnetic resonance spectroscopy. J Magn Reson Imaging 32:148–154PubMedCrossRef
20.
go back to reference Yu H, McKenzie CA, Shimakawa A, et al. (2007) Multiecho reconstruction for simultaneous water–fat decomposition and T2* estimation. J Magn Reson Imaging 26:1153–1161PubMedCrossRef Yu H, McKenzie CA, Shimakawa A, et al. (2007) Multiecho reconstruction for simultaneous water–fat decomposition and T2* estimation. J Magn Reson Imaging 26:1153–1161PubMedCrossRef
21.
go back to reference Van Huffel S, Chen H, Decanniers C, Van Hecke P (1994) Algorithm for time-domain NMR data fitting based on total least squares. J Magn Reson A 110:228–237CrossRef Van Huffel S, Chen H, Decanniers C, Van Hecke P (1994) Algorithm for time-domain NMR data fitting based on total least squares. J Magn Reson A 110:228–237CrossRef
22.
go back to reference Marti-Bonmati L, Alberich-Bayarri A, García-Martí G, et al. Imaging biomarkers, quantitative imaging and bioengineering. Radiología (in press). Marti-Bonmati L, Alberich-Bayarri A, García-Martí G, et al. Imaging biomarkers, quantitative imaging and bioengineering. Radiología (in press).
23.
go back to reference Hussein R, Engelmann U, Schroeter A, Meinzer HP (2004) DICOM structured reporting: part 2. Problems and challenges in implementation for PACS workstations. Radiographics 24:897–909PubMedCrossRef Hussein R, Engelmann U, Schroeter A, Meinzer HP (2004) DICOM structured reporting: part 2. Problems and challenges in implementation for PACS workstations. Radiographics 24:897–909PubMedCrossRef
Metadata
Title
Overload hepatitides: quanti-qualitative analysis
Authors
Luis Martí-Bonmatí
Angel Alberich-Bayarri
Javier Sánchez-González
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 2/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9762-5

Other articles of this Issue 2/2012

Abdominal Radiology 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine